Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Biosynex SA, a prominent player in the diagnostics industry, is headquartered in France and operates extensively across Europe and beyond. Founded in 2005, the company has established itself as a leader in the development and manufacturing of rapid diagnostic tests, particularly in the fields of infectious diseases, chronic diseases, and drug testing.
Biosynex is renowned for its innovative product range, which includes unique testing solutions that deliver rapid and reliable results. The company’s commitment to quality and accuracy has positioned it favourably in the competitive diagnostics market, earning recognition for its contributions to public health. With a focus on research and development, Biosynex continues to expand its portfolio, ensuring it meets the evolving needs of healthcare professionals and patients alike.
-16 vs industry average
Biosynex SA’s score of 26 is lower than 42% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Biosynex SA yet.
Biosynex SA, headquartered in France, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Biosynex SA may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information.
In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to address climate change. However, without specific emissions data or commitments, it is unclear how Biosynex SA aligns with these industry standards. As the company continues to operate, it may consider developing and communicating its climate strategy to enhance transparency and accountability in its environmental impact.
No climate goals have been disclosed for Biosynex SA yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more